These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31626354)

  • 1. What do HIV-positive drug users' experiences tell us about their antiretroviral medication-taking? An international integrated literature review.
    Ho IS; Holloway A; Stenhouse R
    Addiction; 2020 Apr; 115(4):623-652. PubMed ID: 31626354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding HIV-positive drug users' experiences of taking highly active antiretroviral treatment: Identity-Values-Conscious engagement model.
    Ho SS; Stenhouse R; Holloway A
    J Clin Nurs; 2020 May; 29(9-10):1561-1575. PubMed ID: 32096574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and Correlates of Reporting Difficulty Taking Antiretroviral Treatment Among HIV-Positive Illicit Drug Users in Vancouver, Canada: A Longitudinal Analysis.
    Yeung B; Mohd Salleh NA; Socías E; Dong H; Shoveller J; Montaner JSG; Milloy MS
    AIDS Behav; 2019 May; 23(5):1250-1257. PubMed ID: 30284081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug use and antiretroviral therapy (ART) interactions: a qualitative study to explore the knowledge, beliefs, adherence, and quality of life of people living with HIV taking ART and illicit drugs.
    Fuster-RuizdeApodaca MJ; Castro-Granell V; Laguía A; Jaén Á; Cenoz S; Galindo MJ
    AIDS Res Ther; 2020 May; 17(1):24. PubMed ID: 32448214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: a systematic review.
    Malta M; Strathdee SA; Magnanini MM; Bastos FI
    Addiction; 2008 Aug; 103(8):1242-57. PubMed ID: 18855813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlates of non-adherence to antiretroviral therapy in a cohort of HIV-positive drug users receiving antiretroviral therapy in Hanoi, Vietnam.
    Jordan MR; Obeng-Aduasare Y; Sheehan H; Hong SY; Terrin N; Duong DV; Trung NV; Wanke C; Kinh NV; Tang AM
    Int J STD AIDS; 2014 Aug; 25(9):662-668. PubMed ID: 24352130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to antiretroviral therapy among HIV-infected drug users: a meta-analysis.
    Malta M; Magnanini MM; Strathdee SA; Bastos FI
    AIDS Behav; 2010 Aug; 14(4):731-47. PubMed ID: 19020970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individual, social, and structural factors affecting antiretroviral therapy adherence among HIV-positive people who inject drugs in Kazakhstan.
    Davis A; McCrimmon T; Dasgupta A; Gilbert L; Terlikbayeva A; Hunt T; Primbetova S; Wu E; Darisheva M; El-Bassel N
    Int J Drug Policy; 2018 Dec; 62():43-50. PubMed ID: 30359872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication adherence in pregnant women with human immunodeficiency virus receiving antiretroviral therapy in sub-Saharan Africa: a systematic review.
    Omonaiye O; Kusljic S; Nicholson P; Manias E
    BMC Public Health; 2018 Jun; 18(1):805. PubMed ID: 29945601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. If You Build It, Will They Use It? Preferences for Antiretroviral Therapy (ART) Adherence Monitoring Among People Who Inject Drugs (PWID) in Kazakhstan.
    Davis A; Sarsembayeva L; Gulyaev V; Primbetova S; Terlikbayeva A; Mergenova G; Remien RH
    AIDS Behav; 2019 Dec; 23(12):3294-3305. PubMed ID: 30741397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies to improve access to and utilization of health care services and adherence to antiretroviral therapy among HIV-infected drug users.
    Cunningham CO; Sohler NL; Cooperman NA; Berg KM; Litwin AH; Arnsten JH
    Subst Use Misuse; 2011; 46(2-3):218-32. PubMed ID: 21303242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting first month adherence due to antiretroviral therapy among HIV-positive adults at Felege Hiwot Teaching and Specialized Hospital, north-western Ethiopia; a prospective study.
    Tegegne AS; Ndlovu P; Zewotir T
    BMC Infect Dis; 2018 Feb; 18(1):83. PubMed ID: 29458343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The opinions of injecting drug user (IDUs) HIV patients and health professionals on access to antiretroviral treatment and health services in Valencia, Spain.
    Garcia de la Hera M; Davo MC; Ballester-Añón R; Vioque J
    Eval Health Prof; 2011 Sep; 34(3):349-61. PubMed ID: 21411470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Damaging what wasn't damaged already": psychological tension and antiretroviral adherence among HIV-infected methadone-maintained drug users.
    Batchelder AW; Brisbane M; Litwin AH; Nahvi S; Berg KM; Arnsten JH
    AIDS Care; 2013; 25(11):1370-4. PubMed ID: 23406479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review and meta-analysis in the effectiveness of mobile phone interventions used to improve adherence to antiretroviral therapy in HIV infection.
    Shah R; Watson J; Free C
    BMC Public Health; 2019 Jul; 19(1):915. PubMed ID: 31288772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How does hard-to-reach status affect antiretroviral therapy adherence in the HIV-infected population? Results from a meta-analysis of observational studies.
    Lin D; Zhang CY; He ZK; Zhao XD
    BMC Public Health; 2019 Jun; 19(1):789. PubMed ID: 31221113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with antiretroviral treatment uptake and adherence: a review. Perspectives from Australia, Canada, and the United Kingdom.
    Bolsewicz K; Debattista J; Vallely A; Whittaker A; Fitzgerald L
    AIDS Care; 2015; 27(12):1429-38. PubMed ID: 26641139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users.
    Roux P; Fugon L; Winnock M; Salmon-Céron D; Lacombe K; Sogni P; Spire B; Dabis F; Carrieri MP;
    Addiction; 2012 Jan; 107(1):152-9. PubMed ID: 21819472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication persistence of HIV-infected drug users on directly administered antiretroviral therapy.
    Ing EC; Bae JW; Maru DS; Altice FL
    AIDS Behav; 2013 Jan; 17(1):113-21. PubMed ID: 22105340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Both improvement and worsening of adherence to antiretroviral treatment can be expected while transitioning HIV-positive adolescents to adult health care.
    Kowalska JD; Popielska J; Wroblewska A; Firląg-Burkacka E; Horban A; Marczyńska M
    Infect Dis (Lond); 2019 Jun; 51(6):463-466. PubMed ID: 30856034
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.